Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068 in the U.S.

prnasiaMarch 11, 2021

Tag: IMP7068 , IMPACT , Wee1 Inhibitor

PharmaSources Customer Service